<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02343822</url>
  </required_header>
  <id_info>
    <org_study_id>CN-14-2117-B</org_study_id>
    <nct_id>NCT02343822</nct_id>
  </id_info>
  <brief_title>Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection</brief_title>
  <acronym>PRPLE</acronym>
  <official_title>Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection in a Double-Blinded Randomized Controlled Study (PRPLE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the ideal dose of PRP for lateral epicondylitis. To see if 2 PRP injections are
      better than a single PRP injection or a saline injection to improve function and pain in
      patients with lateral epicondylitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Is there greater clinical improvement in long term pain and function when patients receive
      two PRP injections instead of one? This is a double-blinded randomized controlled study to
      determine the ideal treatment regimen for treatment of chronic lateral epicondylitis (tennis
      elbow). The investigators will compare pain visual analog scale (VAS) scores and functional
      Disabilities of Arm, Shoulder, and Hand (DASH) Questionnaire scores of patients receiving a
      single PRP injection and two PRP injections.

      The study will be conducted at Kaiser Modesto Sports Medicine involving 532 patients who meet
      strict criteria for chronic lateral epicondylitis (including greater than 2 months of chronic
      lateral epicondylitis and failing at least one other treatment modality). Patients are
      randomly divided between three groups: 234 patients will receive one PRP injection, 234 will
      receive two, and 64 in the control group will receive a saline injection. All participants
      will receive concurrent home based stretching and strengthening exercises. Results are to be
      measured using the Visual Analog Scale (VAS) and Disabilities of Arm, Shoulder, and Hand
      (DASH) Questionnaire on the initial and follow-up visits of 2, 6, and 12 months. Both
      measures have been validated by prior studies. Successful treatment of lateral epicondylitis
      will be defined as a 25% reduction in visual analog score VAS and DASH scores between initial
      and 6 month visits. Average control and experimental groups VAS scores are expected to be 8
      out of 10 with an improvement to 7 and 6 respectively in 6 months. Average control and
      experimental group DASH scores are expected to be 49 with an improvement to 44 and 28
      respectively in 6 months.

      PRP is an effective treatment in reducing pain of chronic lateral epicondylitis. This study
      aims to prove there is greater clinical improvement in long term pain and function when
      patients receive two PRP injections instead of one.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>6 months</time_frame>
    <description>VAS Score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Function</measure>
    <time_frame>6 months</time_frame>
    <description>DASH Score</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">532</enrollment>
  <condition>Tennis Elbow</condition>
  <condition>Lateral Epicondylitis</condition>
  <arm_group>
    <arm_group_label>Multiple PRP Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 PRP Injections 2 months apart</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single PRP Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 PRP Injection and Saline Injection 2 months apart</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline Injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 Saline Injections 2 months apart</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Platelet Rich Plasma Injection</intervention_name>
    <description>Plasma component of blood rich in growth factors
-during the injection, 5 needle fenestrations will be done to help stimulate blood flow to the area for healing</description>
    <arm_group_label>Multiple PRP Injection</arm_group_label>
    <arm_group_label>Single PRP Injection</arm_group_label>
    <other_name>PRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline Injection</intervention_name>
    <description>Saline
-during the injection, 5 needle fenestrations will be done to help stimulate blood flow to the area for healing</description>
    <arm_group_label>Single PRP Injection</arm_group_label>
    <arm_group_label>Saline Injection</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Lateral epicondylitis - diagnosed by orthopedic or sports medicine physicians / 2
             separate examinations (examination at referral / confirmatory examination at time of
             injection)

          2. Pain at the lateral epicondyle on direct palpation

          3. Pain with resistive wrist extension and/or supination

          4. No clinical findings at annular ligament, radiocapitellar joint, or PIN (posterior
             interosseous nerve syndrome)

          5. No underlying bone pathology

          6. Symptoms present for &gt; 3 months

          7. Visual analog score (VAS) that is &gt;= 5/10

          8. Last steroid injection &gt; 3 months

          9. Failed previous therapy (&gt; = 4 weeks of strap, splint, cast, injection or any other
             accepted therapy without satisfactory pain or function)

        Exclusion Criteria:

          1. Age &lt; 18 years

          2. Pregnant

          3. Symptomatic Carpal Tunnel syndrome on the affected side

          4. History of cervical radiculopathy

          5. History of Diabetes Mellitus, Rheumatoid Arthritis, hepatitis

          6. Blood disorder

          7. No immunocompromised patients (Human ImmunoDeficiency Virus, cancer, immunomodulator
             therapies)

          8. Oral Nonsteroidal Antiinflammatory in the past 1 week or Steroid Drug use in the past
             3 months

          9. Participation in a workers' compensation program or planning to apply for the program
             and/or any ongoing, pending, or planned legal action as a result of elbow pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wais N Arsala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>Modesto</city>
        <state>California</state>
        <zip>95356</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Anitua E, Sanchez M, Nurden AT, Zalduendo M, de la Fuente M, Orive G, Azofra J, Andia I. Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A. 2006 May;77(2):285-93.</citation>
    <PMID>16400654</PMID>
  </reference>
  <results_reference>
    <citation>Krogh TP, Bartels EM, Ellingsen T, Stengaard-Pedersen K, Buchbinder R, Fredberg U, Bliddal H, Christensen R. Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials. Am J Sports Med. 2013 Jun;41(6):1435-46. doi: 10.1177/0363546512458237. Epub 2012 Sep 12. Review.</citation>
    <PMID>22972856</PMID>
  </results_reference>
  <results_reference>
    <citation>Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006 Nov;34(11):1774-8. Epub 2006 May 30.</citation>
    <PMID>16735582</PMID>
  </results_reference>
  <results_reference>
    <citation>Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, Ramsey ML, Karli DC, Rettig AC. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014 Feb;42(2):463-71. doi: 10.1177/0363546513494359. Epub 2013 Jul 3.</citation>
    <PMID>23825183</PMID>
  </results_reference>
  <results_reference>
    <citation>Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010 Feb;38(2):255-62. doi: 10.1177/0363546509355445.</citation>
    <PMID>20448192</PMID>
  </results_reference>
  <results_reference>
    <citation>Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011 Jun;39(6):1200-8. doi: 10.1177/0363546510397173. Epub 2011 Mar 21.</citation>
    <PMID>21422467</PMID>
  </results_reference>
  <results_reference>
    <citation>Arsala W, Sharpe F. Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections With No Greater Positive Effect Than A Single Platelet-Rich Plasma Injection. Med&amp;Science in Sprts&amp;Exercise. 2012 May44(5):S82</citation>
  </results_reference>
  <results_reference>
    <citation>Kennedy JC, Willis RB. The effects of local steroid injections on tendons: a biomechanical and microscopic correlative study. Am J Sports Med. 1976 Jan-Feb;4(1):11-21.</citation>
    <PMID>937623</PMID>
  </results_reference>
  <results_reference>
    <citation>Taylor DW, Petrera M, Hendry M, Theodoropoulos JS. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med. 2011 Jul;21(4):344-52. doi: 10.1097/JSM.0b013e31821d0f65. Review.</citation>
    <PMID>21562414</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2015</study_first_submitted>
  <study_first_submitted_qc>January 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <last_update_submitted>June 6, 2017</last_update_submitted>
  <last_update_submitted_qc>June 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PRP</keyword>
  <keyword>Platelet Rich Plasma</keyword>
  <keyword>Lateral Epicondylitis</keyword>
  <keyword>Lateral Epicondylopathy</keyword>
  <keyword>Lateral Epicondylosis</keyword>
  <keyword>Chronic Lateral Epicondylitis</keyword>
  <keyword>PRPLE</keyword>
  <keyword>Multiple PRP Injections</keyword>
  <keyword>Multiple PRP</keyword>
  <keyword>Platelet-Rich Plasma</keyword>
  <keyword>Tennis Elbow</keyword>
  <keyword>Double Blinded Randomized Controlled</keyword>
  <keyword>Multiple vs Single PRP injections</keyword>
  <keyword>prp tennis elbow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

